WDR5 and synovial sarcoma: Leveraging on the cancer cell line dependency dataset, the medicinal chemistry tool compounds and integrated genomics and molecular oncology approaches, we here report the tryptophan-aspartic acid (W-D) repeat containing protein 5 (WDR5) to be a vulnerability and drug target in SS.